Healthcare -
Biotechnology - NASDAQ - US
$ 2.475
-8.67 %
$ 176 M
Market Cap
-1.63
P/E
CCCC - CAPITAL EXPENDITURES
Capital Expenditures CCCC - C4 Therapeutics, Inc.
-1.71 M
LAST VALUE
-15.65%
2 YEAR CAGR
8.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR